Lyophilization raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-05-25. Anything still debated is marked as such rather than presented as settled.
Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.
Animal work has examined the peptide in models of cardiac injury, skin wounding, and corneal repair, with reported outcomes covering cell migration, inflammatory cell influx, and tissue remodeling. Several of those experiments used the full-length protein or longer fragments instead of the seven-residue sequence, which makes direct comparison between reports difficult. Results are generally described as tissue-dependent, and effect sizes vary considerably across laboratories. Independent replication is uneven, so the overall picture is incomplete rather than settled.
Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.
Purity and identity are separate measurements and are often confused. Reverse-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, reports the share of total peak area belonging to the target compound. Mass spectrometry by electrospray or matrix-assisted laser desorption then checks whether the observed mass matches the expected sequence. Neither measurement alone shows that a vial holds the intended peptide. Peptide content, meaning the fraction of vial mass that is genuine peptide rather than counter-ion, water or residual acid, is reported separately and is frequently lower than the stated purity figure.
The regulatory position is broadly consistent across major jurisdictions: no thymosin beta-4 fragment is an approved medicine, and laboratory material is commonly labelled as not intended for human consumption. Anti-doping rules in sport list thymosin beta-4 and its fragments among prohibited peptide hormones. Because these products travel through research-chemical channels rather than pharmaceutical supply chains, quality varies considerably between vendors. Independent testing of identity, purity and sterility is the only dependable check, and a certificate of analysis describes one batch rather than a supplier's whole catalogue.
Lyophilized peptide powder is normally held desiccated at −20 °C, with −80 °C used for longer storage periods. Allowing a sealed vial to reach room temperature before opening is standard practice, because condensation forming on cold powder introduces moisture. Once dissolved, solutions are typically kept cold and shielded from light. Repeated freeze-thaw cycles are avoided because they encourage aggregation and gradual loss of material. These conventions are general to synthetic peptides rather than unique to any one sequence.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | Thymosin beta-4 fragment; TB4 fragment | Naming is inconsistent across suppliers and publications |
| Reported sequence | Ac-LKKTETQ | Corresponds to residues 17-23 of the parent protein |
| Frequently cited registry number | 77591-33-4 | Associated with full-length thymosin beta-4 rather than the fragment |
| Common supplied form | Freeze-dried solid | Often presented as an acetate or trifluoroacetate salt |
| Regulatory treatment | Varies by country | Frequently handled as a research chemical; not broadly approved as a therapeutic |
TB-500 is a laboratory label applied to a short synthetic peptide that is widely described as a fragment of thymosin beta-4, an actin-binding protein present in most mammalian cells. Suppliers and review articles usually present TB-500 as the N-terminal region of that protein, but the exact sequence attached to the name is not consistent across sources. Some product descriptions list a seven-residue chain; others use the label loosely for the parent protein itself. Because of that variation, any technical discussion of TB-500 needs to state which sequence is meant.
Thymosin beta-4 contains 43 amino acids and has a reported molecular mass near 4963 Da. The short fragment most often associated with the TB-500 label, an acetylated chain beginning LKKTETQ, has a reported mass near 889 Da, so the two are easily separated in analytical work. Mass spectrometry and amino acid analysis can confirm which material is present in a given sample. Statements treating TB-500 and thymosin beta-4 as interchangeable are therefore imprecise, even though the two appear together in much of the same literature.
Interest in the compound comes largely from studies of the parent protein, which participates in actin sequestration, cell migration and tissue repair processes. Whether a short fragment reproduces those activities is a separate question that remains open in the published record. Many summaries describe mechanisms by analogy to thymosin beta-4 rather than from direct measurements on the fragment. Claims about activity should be treated as provisional unless a cited study specifies the exact peptide, its purity and the assay used.
Several names appear in scientific and commercial contexts for this peptide. The label TB-500 is informal and does not follow standard biochemical nomenclature. Research articles more often describe the compound as a thymosin beta-4 fragment, Tβ4 fragment, or by its sequence Ac-LKKTETQ. Confusing TB-500 with full-length thymosin beta-4 can lead to incorrect assumptions about activity because the fragment lacks the remaining residues of the parent protein. The relationship between fragment and parent protein remains an active area of study.
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
TB-500 is a synthetic heptapeptide with the sequence Ac-LKKTETQ. It corresponds to a short N-terminal region of thymosin beta-4, a 43-amino-acid protein found in many cell types. The fragment contains an actin-binding motif, which is one reason it appears in laboratory studies of cell migration and cytoskeletal dynamics. TB-500 is not the full-length protein and is produced as a research chemical rather than an approved therapeutic agent. Its molecular weight is approximately 889 Da.
== Controversies and legal troubles == In June 2016, Bay Area bands Wax Idols and King Woman abruptly ended their tour with Pentagram, citing instances of harassment and unprofessional conduct. Hether Fortune of Wax Idols and Kristina Esfandiari of King Woman stated that they and their bandmates had been "treated really poorly & harassed in gross ways," leading them to withdraw from the tour. Pentagram's management labeled the situation as "unfounded and grossly opportunistic," claiming that after a few nights on tour, the bands "simply disappeared, posted negatively about us on social media, and then headed over to the show that was previously set up for them that very night." In 2017, Liebling was arrested and charged with first-degree assault and physical abuse/injury of a vulnerable adult, later revealed to be his, at the time, 87-year-old mother Diane Liebling. He entered into a plea agreement, resulting in him pleading guilty to the abuse/neglect charge while maintaining his innocence regarding the first-degree assault charge. In October 2017, Liebling was sentenced to eighteen months in the Montgomery County Detention Center and three years of probation upon release. During Liebling's incarceration, Pentagram continued their US tour and performed in Europe without him, with Victor Griffin taking over on vocals. Previously, Liebling had been charged once for violating a restraining order and multiple times for drug possession.
== Education == After graduating from National Taiwan University, Chen completed doctoral studies in the United States and earned his Ph.D. in physical chemistry from Iowa State University in 1997 under professor Cheuk-yiu Ng. She then completed post-doctoral research at Ames Laboratory in 1997, and then at Yuan-Pern Lee's group at National Tsing Hua University in 1999.
These are taxonomy (discovering, describing, and naming species), nomenclature (ensuring the correct and universally accepted naming of those species), phylogeny (inferring the evolutionary relationships among species), and classification (arranging species into higher-order groups like genera, families, and orders). These activities are interdependent. For example, naming a new species (an act of taxonomy) automatically places it within a genus, implicitly hypothesizing a relationship to other members of that genus. Likewise, classifications are continually revised as phylogenetic studies uncover more natural (evolutionarily valid) groupings. A guiding principle in modern systematics is to ensure that each recognized group includes all descendants of one common ancestor (a condition called monophyly). Groupings based only on superficial similarity rather than real ancestry are considered artificial; when studies reveal such cases, the groups are reorganized to reflect true evolutionary lineages. In practice this means many traditional lichen groups defined by convenient field characters (such as all "crustose" lichens or all lichens with a certain type of fruiting body) have been dismantled, and their members redistributed, to ensure that each genus or family reflects a single evolutionary lineage. Lichen systematics has been revolutionized in recent decades by molecular biology and genomics. DNA sequencing now allows researchers to resolve cryptic species and deep evolutionary relationships that were impossible to discern from morphology alone.
Secondary radionuclides in a decay chain will occur in proportion to their half-lives, so short-lived ones will be very rare. For example, polonium can be found in uranium ores at a concentration about 1 part 1010 of uranium (0.1 mg per metric ton) by calculating the ratio of half-lives of polonium-210 to uranium-238, its ultimate parent.
Sources: en.wikipedia.org
== History == Chloroeremomycin was discovered by Eli Lilly in the 1980s. In the 1990s, researchers at Eli Lilly developed biphenyl-chloroeremomycin, now known as oritavancin, as a functionalized derivative of chloroeremomycin to combat rising antibacterial resistance to vancomycin. The chloroeremomycin gene cluster was sequenced by van Wageningen et al in 1998. After the publication, many groups expressed the genes and conducted experiments to understand how chloroeremomycin and, by extension, vancomycin are biosynthesized.
== History == The institution was founded on 13 April 1920 as Government College, Multan, with its first campus at Chowk Katchery in the city. It was renamed Government Emerson College in 1933 in honour of Sir Herbert William Emerson (1881–1962), the then Governor of Punjab in British India, who had earlier served as Deputy Commissioner of Multan. The college was relocated in 1963 to a new and larger campus on Bosan Road, accommodating an expanded enrolment that included postgraduate study. The original Chowk Katchery site was subsequently allocated to the Government College for Women, which later became part of the Government Women University, Multan. Following the passage of the Emerson University, Multan Ordinance VI of 2021, the Government of Punjab's Higher Education Department issued a notification on 15 February 2021 reconstituting Government Emerson College, Multan as Emerson University, Multan under Section 3(1) of the ordinance. The reconstitution was subsequently consolidated by the Provincial Assembly of the Punjab through Punjab Act VIII of 2021, which provided the university's statutory framework. The university is recognised by the Higher Education Commission of Pakistan. Some teaching staff at the predecessor college protested the reconstitution at the time, arguing that a separate new university should have been established rather than upgrading an existing institution.
=== Domains and motifs === There are no known transmembrane domains for C3orf62. C3orf62 has a KKXX-like motif in the C-terminus meaning C3orf62 may be responsible for retrieval of endoplasmic reticulum (ER) membrane proteins from the Golgi apparatus.
Sources: en.wikipedia.org
The leading proposal involves sequestration of monomeric actin, which would alter cytoskeletal turnover and cell movement. The actin-binding motif shared with the parent protein is central to that idea. Direct confirmation in whole organisms remains limited.
Very few controlled human studies focus on the seven-residue sequence itself. Most clinical data concern the full-length protein in cardiac or ophthalmic settings. Conclusions drawn for one form should not be assumed to transfer to the other.
Detection normally relies on reversed-phase liquid chromatography paired with mass spectrometry. Chromatographic retention time establishes the expected elution window, and the mass spectrum confirms the molecular ion. Immunoassays exist but can cross-react with related peptides.
Desiccated storage at −20 °C is conventional, with −80 °C for extended periods. Vials should be warmed to room temperature before opening to prevent condensation on the powder.